advanced search

PREFILLED SYRINGES

CREATING PREFILLABLE SYRINGES FOR THE BIOLOGICS MARKET
PREFILLED SYRINGES
Fabian Stöcker
CREATING PREFILLABLE SYRINGES FOR THE BIOLOGICS MARKET
Nicolas Eon and Fabian Stöcker discuss syriQ BioPure®, a high-end prefillable syringe for biologics, which integrates seamlessly with autoinjectors and an innovative filling platform.
AUTOINJECTOR TRAINER INNOVATIONS TO ENHANCE THE PATIENT EXPERIENCE
PREFILLED SYRINGES
Joe Reynolds
AUTOINJECTOR TRAINER INNOVATIONS TO ENHANCE THE PATIENT EXPERIENCE
Joe Reynolds looks at the benefits offered by Noble's innovative agitator needle simulation tip – which can be incorporated into several types of autoinjector trainers – and reviews the development process.
/H&B/’S FOUR-STEP-TECHNOLOGY
PREFILLED SYRINGES
Tobias Morlok
/H&B/’S FOUR-STEP-TECHNOLOGY
Tobias Morlok outlines how the company’s Four-Step-Technology approach ensures that devices are totally safe to use by protecting against inappropriate use in several ways and at four key stages.
MAKING SELF-ADMINISTRATION POSSIBLE FOR ALL PATIENTS
PREFILLED SYRINGES
Carl Dabruzzi
MAKING SELF-ADMINISTRATION POSSIBLE FOR ALL PATIENTS
At West, extensive human factors studies were carried out to help create the SelfDose™ patient-controlled injector, designed for patients who have dexterity problems. Carl Dabruzzi, Director, Product Management, Self-Injections Systems explains more.
EXTRACTABLES AND LEACHABLES FOR INJECTION DEVICES
EXPERT VIEW
Mark Turner
EXTRACTABLES AND LEACHABLES FOR INJECTION DEVICES
Mark Turner explains the process involved in ensuring that pharmaceutical containers do not inadvertently transmit toxic substances, while maintaining the effectiveness of the active pharmaceutical ingredients (APIs).
PHARMA PARTNERING CONSIDERATIONS FOR INJECTION DEVICE COMPONENTS
EXPERT VIEW
Adam Shain
PHARMA PARTNERING CONSIDERATIONS FOR INJECTION DEVICE COMPONENTS
In the modern world of injectable drugs, one of the major considerations for pharma is choosing partner companies for the development and manufacture of the injection device components. Adam Shain, discusses several of the considerations that go into ensuring that the best possible partner is selected.
THE SECRET TO A SINGLE AUTOINJECTOR DESIGN FOR MULTIPLE MEDICATIONS
PREFILLED SYRINGES
David Philbrick
THE SECRET TO A SINGLE AUTOINJECTOR DESIGN FOR MULTIPLE MEDICATIONS
The autoinjector market is booming and is predicted to continue doing so for some time to come. In order to capitalise on this, pharma companies are looking to use their autoinjectors for multiple medications. David Philbrick presents the case for bringing on metal component manufacturers in the initial design phase to make the most out of the crucial expertise they can offer.
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
PREFILLED SYRINGES
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
SHL details its latest offerings in the world of biologics, as well as its partnership with QuiO, a speciality digital healthcare start-up, to develop injectables in the connected healthcare space.
FROM PREFILLED SYRINGES TO COMBI-FILLING
EXPERT VIEW
Klaus Ullher
FROM PREFILLED SYRINGES TO COMBI-FILLING
Klaus Ullherr summarises the state of modern packaging technology in the pharmaceutical industry in the light of the biotech boom, ready-to-fill and pre-sterilised containers and the trend towards individualised healthcare.
CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED
PREFILLED SYRINGES
Pascal Dugand
CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED
Pascal Dugand relates a study conducted by Nemera to determine a way to optimise the transition from needle insertion to syringe emptying for parenteral devices. This piece was originally presented as a poster at PDA Vienna 2017.
AN OPTIMISED PLATFORM FOR HIGHLY SENSITIVE BIOLOGICS
PREFILLED SYRINGES
Alessio Bonati
AN OPTIMISED PLATFORM FOR HIGHLY SENSITIVE BIOLOGICS
Alessio Bonati discusses the problematic interactions between drugs and their primary containers and goes on to introduce the Alba platform, Ompi’s range of primary glass containers designed to unify drug-container interactions over a product’s lifecycle.
PREFILLABLE SYRINGE DEVELOPMENTS TO MEET BIOTECH DRUG NEEDS
PREFILLED SYRINGES
Claudia Petersen
PREFILLABLE SYRINGE DEVELOPMENTS TO MEET BIOTECH DRUG NEEDS
Claudia Petersen looks at the technological advances being made to ensure prefillable syringes are compatible with protein-based, biotech-derived drugs.
SUNDEEP KANKANALA, BD
INTERVIEW
Sundeep Kankanala
SUNDEEP KANKANALA, BD
Sundeep Kankanala discusses the challenges faced by today’s biopharmaceutical industry, in particular those posed by the need for large volumes and the issues caused by the use of silicone in prefilled syringes.
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
PREFILLED SYRINGES
Bill Welch
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
There are some device design considerations that are common across the spectrum of biologics development. Bill Welch discusses these considerations, highlighting the advantage conferred by accounting for them early in the product lifecycle.
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
INTERVIEW
John Merhige
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.
THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
PREFILLED SYRINGES
Karen Guerrero
THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
Karen Guerrero outlines how human factors engineering, now an essential requirement for all new drug delivery combination product approvals, can represent a significant challenge and how BD can help streamline this aspect of the development process.
ADDRESSING HUMAN FACTORS STUDIES AT AN EARLY STAGE
PREFILLED SYRINGES
Jakob Lange
ADDRESSING HUMAN FACTORS STUDIES AT AN EARLY STAGE
Orfeo Niedermann and Jakob Lange provide insights into the development of platform products that offer pharma companies low risks and shorter timelines at an attractive cost, using the examples of the YpsoMate autoinjector and UnoPen pen injector platform products.
A PATIENT-CENTRIC APPROACH TO THERAPY MANAGEMENT
EXPERT VIEW
Karl Hewson
A PATIENT-CENTRIC APPROACH TO THERAPY MANAGEMENT
Karl Hewson and Uri Baruch discuss the challenges presented by chronic illness, and look ahead to a better future of patient-centric treatment, personalised to each individual’s needs.
IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES
PREFILLED SYRINGES
Paul Sullivan
IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES
Paul Sullivan outlines how the growing trend towards patient self-injection, outside of the clinical setting, places an ever greater emphasis on quality training and onboarding. Mr Sullivan specifically explains how such training can help overcome the issue of patient needle fear or anxiety.
A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS
PREFILLED SYRINGES
Andreas Schneider
A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS
Andreas Schneider explores a new value proposition of smart injection systems, introducing how advanced adherence monitoring services resolve some of the key challenges of clinical research practice regarding costs, adherence, data quality and integrity, Dr Schneider explains which technical features are needed for smart devices to provide value-adding adherence monitoring services, using SmartPilot for YpsoMate as a case study.
PRODUCT SHOWCASE: APTAR PHARMA’S PREMIUM PORTFOLIO
PREFILLED SYRINGES
Arnaud Fournier
PRODUCT SHOWCASE: APTAR PHARMA’S PREMIUM PORTFOLIO
For over 50 years Aptar Pharma’s injectables specialists have led the way in developing innovative elastomer solutions. Their commitment to continuous improvement has resulted in elastomer formulations that feature best-in-class extractables and leachables profiles.
DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE & REDUCE ANXIETY
PREFILLED SYRINGES
Joe Reynolds
DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE & REDUCE ANXIETY
Using Noble’s recent partnership with BD to develop trainers for BD’s UltraSafe™ needle safety technology as an example, Joe Reynolds discusses the importance of training devices for the successful onboarding of patients beginning to use self-injected therapeutics, and how Noble’s training devices are designed to be faithful to the look and feel of the real product.
A REVIEW OF REUSABLE AUTO-INJECTORS FOR BIOLOGICAL & BIOSIMILAR DRUGS
PREFILLED SYRINGES
Menachem Zucker
A REVIEW OF REUSABLE AUTO-INJECTORS FOR BIOLOGICAL & BIOSIMILAR DRUGS
From the perspective of the growing biologics and emerging biosimilars markets, Menachem Zucker showcases E3D – Elcam Drug Delivery Devices' mechanical and electronic auto-injector platforms, both of which are reusable devices with disposable cassettes.
DOES THE NEW EU MDR SPELL THE END OF GRANDFATHERING?
EXPERT VIEW
Helen Simmons
DOES THE NEW EU MDR SPELL THE END OF GRANDFATHERING?
Helen Simons and Stephanie Ward describe how the new EU Medical Devices Regulation will impact on “grandfathered” devices that were approved under old regulation and are currently on the market, but do not necessarily comply with current/updated regulatory standards, and explain the potential implications for device manufacturers.
Top